Table 3 Ipsilateral and contralateral risk after treatment based on studies of BRCA genotype and age at diagnosis

Trainer, A. H. et al. (2010) The role of BRCA mutation testing in determining breast cancer therapyNat. Rev. Clin. Oncol. doi:10.1038/nrclinonc.2010.175